BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34246509)

  • 1. Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.
    Huang SY; Lin HH; Yao M; Tang JL; Wu SJ; Chou WC; Hsu SC; Ko BS; Tien HF
    J Formos Med Assoc; 2022 Mar; 121(3):643-651. PubMed ID: 34246509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study.
    Huang SY; Lin HH; Yao M; Tang JL; Wu SJ; Hou HA; Chou WC; Chou SC; Hsu SC; Ko BS; Lu HY; Tsay W; Tien HF
    PLoS One; 2015; 10(9):e0137552. PubMed ID: 26379028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
    Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
    Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorin is a part of the ovarian extracellular matrix in primates and may act as a signaling molecule.
    Adam M; Saller S; Ströbl S; Hennebold JD; Dissen GA; Ojeda SR; Stouffer RL; Berg D; Berg U; Mayerhofer A
    Hum Reprod; 2012 Nov; 27(11):3249-58. PubMed ID: 22888166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of decorin in multiple myeloma (MM) bone marrow microenvironment.
    Nemani N; Santo L; Eda H; Cirstea D; Mishima Y; Patel C; O'Donnell E; Yee A; Raje N
    J Bone Miner Res; 2015 Mar; 30(3):465-70. PubMed ID: 25407518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
    Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
    Br J Haematol; 2013 May; 161(3):373-82. PubMed ID: 23431957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dermatan sulfate proteoglycan decorin modulates α2β1 integrin and the vimentin intermediate filament system during collagen synthesis.
    Jungmann O; Nikolovska K; Stock C; Schulz JN; Eckes B; Riethmüller C; Owens RT; Iozzo RV; Seidler DG
    PLoS One; 2012; 7(12):e50809. PubMed ID: 23226541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.
    Nikolovska K; Renke JK; Jungmann O; Grobe K; Iozzo RV; Zamfir AD; Seidler DG
    Matrix Biol; 2014 Apr; 35():91-102. PubMed ID: 24447999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma.
    Kara IO; Sahin B; Gunesacar R; Unsal C
    Adv Ther; 2006; 23(4):635-45. PubMed ID: 17050506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decorin inhibits the insulin-like growth factor I signaling in bone marrow mesenchymal stem cells of aged humans.
    Wong TH; Chen TY; Tseng KY; Chen ZY; Chen CH; Lin FH; Wu HM; Lin S
    Aging (Albany NY); 2020 Nov; 13(1):578-597. PubMed ID: 33257596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma decorin levels following acute ischemic stroke: correlation with MMP-2 and differential expression in TOAST subtypes.
    Xu YZ; Zhao KJ; Yang ZG; Zhang YH; Zhang YW; Hong B; Liu JM
    Mol Med Rep; 2012 Dec; 6(6):1319-24. PubMed ID: 23026977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.
    Patel KS; Yao J; Raymond C; Yong W; Everson R; Liau LM; Nathanson D; Kornblum H; Wang C; Oughourlian T; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    Sci Rep; 2020 Sep; 10(1):14819. PubMed ID: 32908231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of decorin in the antimyeloma effects of osteoblasts.
    Li X; Pennisi A; Yaccoby S
    Blood; 2008 Jul; 112(1):159-68. PubMed ID: 18436739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role for decorin in delayed-type hypersensitivity.
    Seidler DG; Mohamed NA; Bocian C; Stadtmann A; Hermann S; Schäfers K; Schäfers M; Iozzo RV; Zarbock A; Götte M
    J Immunol; 2011 Dec; 187(11):6108-19. PubMed ID: 22043007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin.
    Järvinen TAH; Ruoslahti E
    Br J Pharmacol; 2019 Jan; 176(1):16-25. PubMed ID: 29847688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of Cartilage Matrix Degeneration and Fibrillation by Decorin in Post-traumatic Osteoarthritis.
    Li Q; Han B; Wang C; Tong W; Wei Y; Tseng WJ; Han LH; Liu XS; Enomoto-Iwamoto M; Mauck RL; Qin L; Iozzo RV; Birk DE; Han L
    Arthritis Rheumatol; 2020 Aug; 72(8):1266-1277. PubMed ID: 32162789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowered Decorin With Aberrant Extracellular Matrix Remodeling in Aqueous Humor and Tenon's Tissue From Primary Glaucoma Patients.
    NikhalaShree S; Karthikkeyan G; George R; Shantha B; Vijaya L; Ratra V; Sulochana KN; Coral K
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4661-4669. PubMed ID: 31725165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly.
    Daquinag AC; Gao Z; Fussell C; Sun K; Kolonin MG
    Cells; 2020 Dec; 9(12):. PubMed ID: 33317052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.